Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 1999, p. 254-259, Vol. 6, No. 2
Unit of Emerging and Re-Emerging
Diseases,1
Retrovirology,2 and
Parasitology,3 International Center for
Medical Research (CIRMF), Franceville, Gabon
Received 28 July 1998/Returned for modification 5 October
1998/Accepted 17 December 1998
All NK cells potentially lytic for autologous cells but not
expressing self-major histocompatibility complex (MHC)-reactive receptors could be eliminated by a negative selection mechanism during
ontogeny. This idea is based on the existence of a NK cell subset
expressing a specific inhibitory receptor for allogeneic MHC alleles.
As ancestral haplotypes of the MHC appear to define identical MHC
haplotypes in unrelated individuals, unrelated individuals having the
same ancestral haplotype should also have the same NK-defined
allospecificities that have been shown to map to the human MHC. To test
this prediction, multiple cell lines from unrelated individuals having
the same ancestral haplotypes were tested for the NK-defined
allospecificities. It was found that cells having the same ancestral
haplotypes do have the same NK-defined specificities. Furthermore, the
NK-defined phenotype of cells that possess two different ancestral
haplotypes can be predicted from the NK-defined phenotypes of unrelated
cells that are homozygous for the ancestral haplotypes concerned.
Although the group 1 and 2 NK-defined allospecificities can be
explained to some extent by HLA-C alleles, evidence is presented that
additional genes may modify the phenotype conferred by HLA-C.
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Alloreactivity and Association of Human Natural
Killer Cells with the Major Histocompatibility Complex
*
Corresponding author. Mailing address: Emerging and
Re-Emerging Diseases Unit, Centre International de Recherches
Médicales de Franceville CIRMF, B.P. 769, Franceville, Gabon.
Phone: (241) 67 70 92. Fax: (241) 67 72 95. E-mail:
emavoung{at}cirmf.sci.ga.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |